Evidence map›Paper›PMID 40238333›Full record

ArticleFoods (Basel, Switzerland)2025

Phenotypic and Genomic Insights into

Chonticha Romyasamit, Komwit Surachat, Nawanwat C Pattaranggoon, Pinkanok Suksabay, Uttapol Permpoon, Tae-Gyu Nam, Phoomjai Sornsenee

Abstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Foods (Basel, Switzerland) · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chonticha RomyasamitDepartment of Medical Technology, School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat 80160, Thailand.ORCID 0000-0003-1403-1628
Komwit SurachatDepartment of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand.ORCID 0000-0001-7793-7561
Nawanwat C PattaranggoonFaculty of Medical Technology, Rangsit University, Muang Pathumthani, Pathumthani 12000, Thailand.
Pinkanok SuksabayDepartment of Medical Technology, School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat 80160, Thailand.
Uttapol PermpoonDepartment of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University ERICA, Ansan 15588, Republic of Korea.ORCID 0009-0004-6139-3773
Tae-Gyu NamDepartment of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University ERICA, Ansan 15588, Republic of Korea.
Phoomjai SornseneeDepartment of Family and Preventive Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.ORCID 0000-0001-6992-033X

Funding

the Office of the Permanent Secretary, Ministry of Higher Education, Science, Research, and Inno-vation (OPS MHESI), Thailand Science Research and Innovation (TSRI) RGNS 65-183
6 · The paper itself

Abstract

The increasing prevalence of multidrug-resistant (MDR) pathogens, particularly ESKAPE bacteria, necessitates alternative antimicrobial strategies. Probiotics, particularly lactic acid bacteria, protect against pathogenic infections. This study aimed to characterize

Indexed as

antimicrobial activityESKAPE pathogensprobioticsSchleiferilactobacillus harbinensiswhole-genome sequencing

Identifiers

PMID40238333
PMCPMC11989002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.